NEWSLETTER
Your exclusive source
of ATMP insights and updates
Stay updated on ATMP innovation and rare disease care across Europe
Have you heard about CREATIC LabtoP Talks ~ From Lab to Patient?
On November 22, 2024, the CREATIC team hosted the very first LabtoP Talk – a conversation on how Advanced Therapy Medicinal Products (ATMPs) make their way from the laboratory to the patient. In this recorded session, experts discuss the Hospital Exemption as a practical pathway for ATMP delivery. Whether you're a healthcare professional, researcher, policymaker, or simply curious about the future of medical innovation, this talk offers valuable insights into how cross-sector collaboration can shape access to advanced therapies.
About ATMP Newsletter
The CREATIC ATMP Newsletter is a joint effort by Masaryk University and the University of Copenhagen. MUNI | CREATIC (Masaryk University) has established a partnership with the University of Copenhagen, Leipzig University, and the Fraunhofer Institute for Cell Therapy and Immunology IZI to build a center of excellence in research and development focused on Advanced Therapy Medicinal Products (ATMPs). This Czech‑Danish collaboration behind the newsletter brings key updates, expert perspectives, and relevant regulatory developments in the ATMP and rare disease ecosystem, with a focus on Central Europe.
Highlights from the Latest Issue
The root causes of unavailability of innovative medicines and delay in access
MHRA publishes ‘world first' decentralised manufacturing guidance
From Tissue Donation To Distribution: Understanding EU Regulatory Requirements In Cell Therapy Clinical Trials
In this fourth edition of the CREATIC ATMP Newsletter, we turn our focus to the rapidly shifting landscape of advanced therapies in Europe. This issue brings a closer look at how clinical infrastructures, regulatory frameworks, and research collaborations are adapting to keep pace with scientific progress. We highlight emerging case studies from across Central Europe, new momentum in cross-border clinical research, and the practical implications of evolving regulatory guidance for ATMP developers.
You’ll also find insights into the organizational challenges that still limit the translation of advanced therapies into real-world care – from workforce capacity and manufacturing readiness to coordination across national health systems. Together, these perspectives offer a grounded view of where the field is heading and what still needs to be done to ensure that innovative treatments can reach patients efficiently, safely, and at scale.
ATMP Newsletter Archive
Browse previous editions of the CREATIC ATMP Newsletter and stay informed about key developments in advanced therapies.
Issue #3 (online) | DOWNLOAD .pdf
Issue #1 (online) | DOWNLOAD .pdf | Issue #2 (online) | DOWNLOAD .pdf
Stay in the Loop!
Get quartely updates on advanced therapies, expert insights, and cross-border collaboration - straight to your inbox.
Partners in Consortium
